Presentation

December 15^th, 2011

Dear Colleague,

After the large success and attendance at our 4th edition of CTAD 2011 last November in San Diego, USA we are proud to announce the dates for our 5th edition of Clinical Trials on Alzheimer’s Disease sponsored by the UC San Diego School of Medicine which will take place in Monte Carlo, Monaco on October 29-31, 2012.

 

At CTAD 2012 we will once again bring the key leaders involved in clinical trials to appreciate the full spectrum of AD from an asymptomatic stage through dementia, discuss the development of the next generation of Alzheimer’s disease treatments as well as learn to harmonize the various neuroimaging techniques and their analyses.

Alzheimer’s disease is one of the most important health challenges worldwide. This conference will also focus on new results, actual and future methodological issues, disease-modifying outcomes, biomarkers, fundamental research, new therapeutics, biomarkers and impact on the Healthcare economy. CTAD will again be the perfect opportunity to hear about the clinical experiences of international teams, exchange with your peers on the difficulties and challenges of Alzheimer’s disease and take home some hands-on therapeutic and methodological tools to improve and reinforce your AD clinical trials teams.

 

 

We look forward to seeing you again in Monte Carlo!

Paul Aisen - Jacques Touchon - Bruno Vellas – Mike Weiner

ORGANIZING COMMITTEE